NASDAQ: ADMP $70 Million Small-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 81%. 1 Year Return 0%. 2021 YTD Return 44%. Since Earnings 8%.
The 52 Week Low is $0.27 set on Wed, Mar 18, 2020.
The 52 Week High is $1.51 set on Wed, Jul 29, 2020.
The All-Time High is $18.53 set on Thu, Nov 8, 2012.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Adamis Pharmaceuticals Corp trades on the NASDAQ. ADMP's market cap is 70.00 Million.
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company. It is focused on developing and commercializing products in various therapeutic areas, including respiratory disease, allergy, and opioid overdose. Its SYMJEPI (epinephrine) Injection products are used in the emergency treatment of acute allergic reactions, including anaphylaxis. Adamis is developing additional products, including a naloxone injection product candidate, ZIMHI, for the treatment of opioid overdose, and other products for the treatment of asthma and COPD. Its subsidiary compounds sterile prescription drugs, and certain nonsterile drugs for use by hospitals, clinics, and surgery centers throughout the U.S.
For Starters
Track your portfolio and more.
